Showing results (551-560 of 1,988) with videos related to
Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|December 4, 2023
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort studyYan Hiu Athena Lee, Jeremy Man Ho Hui, Chi Ho Leung, et al.Prostate Cancer and Prostatic Diseases|September 2, 2023
Histopathological concordance between prostate biopsies and radical prostatectomy specimens-implications of transrectal and transperineal biopsy approachesM J Hagens, L L A Ribbert, A Jager, et al.Prostate Cancer and Prostatic Diseases|September 7, 2023
Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratificationNeal D Shore, Judd W Moul, Kenneth J Pienta, et al.Prostate Cancer and Prostatic Diseases|August 24, 2023
Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly menMichael Zhu, Mustufa Babar, Noah Hawks-Ladds, et al.Prostate Cancer and Prostatic Diseases|October 23, 2023
Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages-dependence on GPR120Pei Liang, Susanne M Henning, Tristan Grogan, et al.Prostate Cancer and Prostatic Diseases|October 11, 2023
Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 menMatthew Epstein, Kaynaat Syed, John Danella, et al.Prostate Cancer and Prostatic Diseases|October 26, 2023
Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization studySteve Kaplan, Ronald P Kaufman, Thomas Mueller, et al.Prostate Cancer and Prostatic Diseases|September 25, 2023
ANO7 African-ancestral genomic diversity and advanced prostate cancerJue Jiang, Pamela X Y Soh, Shingai B A Mutambirwa, et al.Prostate Cancer and Prostatic Diseases|July 8, 2023
The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A reviewRand N Wilcox Vanden Berg, Thomas Zilli, Vérane Achard, et al.Prostate Cancer and Prostatic Diseases|June 30, 2023
Prostate cancer in New York City: impact of neighborhood level social determinants of careJustin Chestang, Shikun Wang, James B YuPageof 199